Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 10, 2022
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
[ Tue, May 10th 2022
] - WOPRAI
Thomas Shrader Initiated (ATHA) at Strong Buy and Held Target at $33 on, May 10th, 2022
Thomas Shrader of BTIG, Initiated "Athira Pharma, Inc." (ATHA) at Strong Buy and Held Target at $33 on, May 10th, 2022.
Thomas has made no other calls on ATHA in the last 4 months.
There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Thomas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Thomas
- Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022
